Astrazeneca plc ADR Inc. (AZN) Price Performance: The Role of Share Buybacks and Stock Splits

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price loss of -6.17% this year. Over the last six months, there has been a stronger performance of -14.55%. The price of AZN leaped by -0.33% during the last 30 days period. For the last 5-days stocks have slided -0.13%.

The present stock price for Astrazeneca plc ADR (AZN) is $63.62. In the last trading session, the stock made a considerable jump, reaching $64.42 after an opening price of $64.28. The stock briefly fell to $64.01 before ending the session at $64.13.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


Astrazeneca plc ADR experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $76.56 on 04/25/23, while the lowest price for the same period was registered at $61.73 on 10/27/23.

52-week price history of AZN Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Astrazeneca plc ADR’s current trading price is -16.90% away from its 52-week high, while its distance from the 52-week low is 3.06%. The stock’s price range during this time has been between $61.73 and $76.56. The trading volume for the Healthcare sector company’s shares reached about 2.09 million for the day, which was lower than the average daily volume of 5.23 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Astrazeneca plc ADR (AZN) has experienced a quarterly decline of -7.49% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 197.21B and boasts a workforce of 83500 employees.

Astrazeneca plc ADR: Analysts’ Ratings Unveiled

As of right now, 24 analysts are rating Astrazeneca plc ADR as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 67.13, with a change in price of -7.14. Similarly, Astrazeneca plc ADR recorded 5,496,877 in trading volume during the last 100 days, posting a change of -10.08%.

AZN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AZN stands at 0.77. Similarly, the long-term debt-to-equity ratio is also 0.62.

AZN Stock Stochastic Average

Today, Astrazeneca plc ADR’s raw stochastic average for the past 50 days stands at 21.45%, indicating a decline from the raw stochastic average of the last 20 days, which was 51.30%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 55.80% and 50.62% respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts